These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 21360011)

  • 21. The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples.
    Oldham J; Lachmann HJ
    Clin Exp Dermatol; 2020 Dec; 45(8):967-973. PubMed ID: 32882069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.
    Cattalini M; Soliani M; Lopalco G; Rigante D; Cantarini L
    Intern Emerg Med; 2016 Sep; 11(6):781-91. PubMed ID: 27221072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periodic fever syndromes.
    Lachmann HJ
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):596-609. PubMed ID: 29773275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
    Bettiol A; Lopalco G; Emmi G; Cantarini L; Urban ML; Vitale A; Denora N; Lopalco A; Cutrignelli A; Lopedota A; Venerito V; Fornaro M; Vannacci A; Rigante D; Cimaz R; Iannone F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periodic fever syndromes.
    Goldsmith DP
    Pediatr Rev; 2009 May; 30(5):e34-41. PubMed ID: 19411331
    [No Abstract]   [Full Text] [Related]  

  • 27. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry.
    Demirkaya E; Saglam C; Turker T; Koné-Paut I; Woo P; Doglio M; Amaryan G; Frenkel J; Uziel Y; Insalaco A; Cantarini L; Hofer M; Boiu S; Duzova A; Modesto C; Bryant A; Rigante D; Papadopoulou-Alataki E; Guillaume-Czitrom S; Kuemmerle-Deschner J; Neven B; Lachmann H; Martini A; Ruperto N; Gattorno M; Ozen S; ;
    J Rheumatol; 2016 Jan; 43(1):154-60. PubMed ID: 26568587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hereditary autoinflammatory diseases.
    Ter Haar NM; Frenkel J
    Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes.
    Zhuang L; Chen J; Yu J; Marathe A; Sahajwalla C; Borigini M; Maynard J; Burckart GJ; Wang Y
    Clin Pharmacol Ther; 2019 Sep; 106(3):557-567. PubMed ID: 30447083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to handle the main drugs to treat autoinflammatory disorders and how we treat common autoinflammatory diseases.
    Koné-Paut I; Dusser P
    G Ital Dermatol Venereol; 2020 Oct; 155(5):574-589. PubMed ID: 32618444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective review of autoinflammatory diseases in Saudi children at a rheumatology clinic.
    Alenazi A; Al Sonbul A; Al Jumaah S; Al Mehaidib A; Al-Mayouf SM
    Ann Saudi Med; 2012; 32(1):43-8. PubMed ID: 22156639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.
    Milota T; Malcová H; Střížová Z; Cebecauerová D; Horváth R
    Cas Lek Cesk; 2022; 161(1):3-10. PubMed ID: 35354288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes.
    Piram M; Koné-Paut I; Lachmann HJ; Frenkel J; Ozen S; Kuemmerle-Deschner J; Stojanov S; Simon A; Finetti M; Sormani MP; Martini A; Gattorno M; Ruperto N;
    Ann Rheum Dis; 2014 Dec; 73(12):2168-73. PubMed ID: 24026675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
    Magnotti F; Malsot T; Georgin-Lavialle S; Abbas F; Martin A; Belot A; Fauter M; Rabilloud M; Gerfaud-Valentin M; Sève P; Duquesne A; Hot A; Durupt S; Savey L; Giurgea I; Grateau G; Henry T; Jamilloux Y
    Ann Rheum Dis; 2021 Jan; 80(1):128-132. PubMed ID: 33037005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fevers and the rheumatologist.
    Manners PJ; Guttinger R
    Indian J Pediatr; 2010 Oct; 77(10):1173-81. PubMed ID: 20953850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What is confirmed in the treatment of autoinflammatory fever diseases?].
    Pankow A; Feist E; Baumann U; Kirschstein M; Burmester GR; Wagner AD
    Internist (Berl); 2021 Dec; 62(12):1280-1289. PubMed ID: 34878558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico validation of the Autoinflammatory Disease Damage Index.
    Ter Haar NM; van Delft ALJ; Annink KV; van Stel H; Al-Mayouf SM; Amaryan G; Anton J; Barron KS; Benseler S; Brogan PA; Cantarini L; Cattalini M; Cochino AV; de Benedetti F; Dedeoglu F; de Jesus AA; Demirkaya E; Dolezalova P; Durrant KL; Fabio G; Gallizzi R; Goldbach-Mansky R; Hachulla E; Hentgen V; Herlin T; Hofer M; Hoffman HM; Insalaco A; Jansson AF; Kallinich T; Kone-Paut I; Kozlova A; Kuemmerle-Deschner JB; Lachmann HJ; Laxer RM; Martini A; Nielsen S; Nikishina I; Ombrello AK; Özen S; Papadopoulou-Alataki E; Quartier P; Rigante D; Russo R; Simon A; Trachana M; Uziel Y; Ravelli A; Schulert G; Gattorno M; Frenkel J
    Ann Rheum Dis; 2018 Nov; 77(11):1599-1605. PubMed ID: 30077992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 inhibition in the treatment of autoinflammatory diseases.
    Koga T; Kawakami A
    Front Immunol; 2022; 13():956795. PubMed ID: 35958618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry.
    Blank N; Kötter I; Schmalzing M; Rech J; Krause K; Köhler B; Kaudewitz D; Nitschke M; Haas CS; Lorenz HM; Krusche M
    Rheumatol Int; 2024 Feb; 44(2):263-271. PubMed ID: 37747561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoinflammatory diseases: an update of clinical and genetic aspects.
    Yao Q; Furst DE
    Rheumatology (Oxford); 2008 Jul; 47(7):946-51. PubMed ID: 18388145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.